JRCT ID: jRCT1030230308
Registered date:25/08/2023
Treatment Preference in Patients with NMOSD
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Neuromyelitis Optica Spectrum Disorders |
Date of first enrollment | 03/08/2023 |
Target sample size | 30 |
Countries of recruitment | |
Study type | Other |
Intervention(s) |
Outcome(s)
Primary Outcome | causal Relationship between Subjective Adverse Event Experience and Impact on Daily Living of Patients with NMOSD |
---|---|
Secondary Outcome | subjective Adverse Event Experience and Importance of Impact on Daily Living of Patients with NMOSD |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | |
Include criteria | Subjects who meet all of the following criteria: (1)Documented diagnosis of NMOSD (2)Anti-aquaporin-4 antibody test positive (3)Patients who are taking or have taken an oral steroid (4)Patients aged 20 years or older at the time of enrollment (5)Must have sufficient understanding to conduct the research (The patient may require assistance in reading aloud, etc. due to visual disturbance.) (6)Individuals who have consented to participate in this research (7)Patients who are living in Japan at the time of enrollment (8)Individuals who have equipment/communication environment to apply for research participation online and perform interviews or respond to questionnaires |
Exclude criteria | Subjects who meet any of the following criteria: (1)Patients who have difficulty in obtaining consent or conducting this research due to a lack of Japanese ability (2)Patietnts who cannot participate in the survey |
Related Information
Primary Sponsor | Yamashita Katsuhisa |
---|---|
Secondary Sponsor | Nishi Kazuhiko |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Tadashi Nagatsuka |
Address | 1-1 Nihonbashi-Muromachi 2-chome, Nihonbashi Mitsui Tower (Reception15F) Chuo-ku, Tokyo Tokyo Japan 1038324 |
Telephone | +81-332816611 |
cma-clinicaltrial@chugai-pharm.co.jp | |
Affiliation | Chugai Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | Katsuhisa Yamashita |
Address | 1-1 Nihonbashi-Muromachi 2-chome, Nihonbashi Mitsui Tower (Reception15F) Chuo-ku, Tokyo Tokyo Japan 1038324 |
Telephone | +81-332816611 |
cma-clinicaltrial@chugai-pharm.co.jp | |
Affiliation | Chugai Pharmaceutical Co., Ltd. |